Bristol-Myers Squibb to Award $1.4 Million for Hepatitis Awareness in Asia

November 3, 2008

Bristol-Myers Squibb Company and the Bristol-Myers Squibb Foundation have announced plans to award $1.4 million in grants focused on hepatitis C prevention and education and the mitigation of the disease in four Asian countries.

The grants are part of Delivering Hope, an umbrella program for Bristol-Myers Squibb’s efforts in the areas of hepatitis awareness, prevention and care. A total of five grants will be awarded, including four individual country grants of $250,000 to support two-year projects in China, India, Taiwan and Thailand, and one multi-country grant of $400,000 to support a collaborative, integrative two-year project involving two or more of these countries.

The Foundation will award grants to universities, health centers or established nonprofit and non-governmental organizations for projects focused on improvement of hepatitis C screening, blood transfusion practices and risk reduction services; implementation and maintenance of infection-control practices within the health care setting; hepatitis C education for lay or community-based health workers; or improvement of prevention methods and determination of risk factors for infection and disease transmission patterns.

According to the company, the grant recipients should have a detailed plan of evaluation and reportable outcomes and must prepare a comprehensive final report at the completion of their projects to enhance the body of knowledge on hepatitis prevention, care and support.

John Damonti, president of Bristol-Myers Squibb Foundation, said: “The grant program in Asia builds on our expertise in addressing health disparities to help coordinate the response to hepatitis in countries where the need is greatest.”

comments powered by Disqus